Oxford BioDynamics Plc, one of the largest spin-out companies from Oxford University has expanded further at Oxford Business Park. The business, which is an existing customer of the Park has taken additional space to expand its state-of-the-art reference laboratory as well as quality control and quality assurance facilities.
Oxford BioDynamics Plc is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry. The company’s award-winning, proprietary technology platform, EpiSwitch™, aims to accelerate the drug discovery and development process, improve the success rate of therapeutic product development and take advantage of the increasing importance of personalised medicine.
Oxford Biodynamics said: “We are extremely pleased to be able to expand our laboratory at the Oxford Business Park. Arlington have been very helpful and flexible in arranging things for us, which has allowed us to develop much needed additional space without needing to shut down our operations for a move to a new building. We like being here, and our expanded facilities mean we should now be able to stay for years to come.”
Dan Williams, Development Director at Arlington said: “It is an exciting time for science of innovation in Oxford and we are delighted to help Oxford BioDynamics Plc with their latest phase of growth, we wish them all the success going forward.”
